Grupo Insud to Build $55 Million Veterinary Drug Facility
Grupo Insud, an Argentinian conglomerate with two pharmaceutical subsidiaries, will spend $55 million to build an animal health manufacturing plant in China. The new facility, which will produce a vaccine to prevent foot-and-mouth disease, represents only the first phase of the company’s China construction plans, though more details were not provided. In addition, Grupo Insud wants to bring human diabetes and cancer treatments to China. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here